Vaccines are not mentioned in the order but there are references to overmedication of children and undue industry influence.
Within hours of Robert F. Kennedy Jr’s confirmation as HHS secretary, President Donald Trump issued an executive order creating a commission to study and report on chronic diseases among children that Kennedy will chair.
Neither the executive order nor the fact sheet that supports it mention vaccines. The fact sheet does, however, mention the prevalence of autism, which antivaccine groups have linked to vaccine. It also mentions the overmedication of children as a “growing concern,” and the order says the commission should, among other issues, assess “the prevalence of and threat” of selective serotonin reuptake inhibitors, antipsychotics, mood stabilizers, stimulants, and weight-loss drugs.
Health insurance is mentioned just once in the policy directives part of the executive order. Federal agencies should ensure availability of expanded treatment options and the flexibility “for health insurance coverage to provide benefits that support beneficial lifestyle changes and disease prevention,” says the order.
Kennedy has talked about undue corporate influence on health and other federal government agencies. The order mentions restoring “the integrity of science, including by eliminating undue industry influence” and establishing “a framework for transparency and ethics review in industry-funded projects.”
The commission is named the Make America Healthy Again commission. Kennedy’s views about vaccines came under sharper scrutiny after he endorsed Trump in August and was seen as headed for influential role if Trump were to win the presidency. But earlier, as an independent presidential candidate, Kennedy broadened his message to chronic disease rates and the poor health of Americans, and today’s executive orders echoes He later attached the slogan Make America Healthy Again, abbreviated to MAHA, to his views and those efforts.
The executive order calls for the commission to submit an assessment of U.S. childhood health within 100 days of the order and within 180, a strategy based on the assessment.
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Dupixent Is Linked to a Higher Risk of Psoriasis in Patients With Atopic Dermatitis
July 8th 2025AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and psoriasis driven by Th17 inflammation. However, newer research has shown that these diseases can overlap in patients and may even share common pathways.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Autoimmune Diseases Almost Double Mental Health Disorder Risk
July 7th 2025The prevalence of autoimmune disease patients with a mental health disorder is almost twice the number of patients without, suggesting there is a link between inflammation and conditions such as depression, anxiety disorder and bipolar disorder.
Read More